Beta Bionics holders back directors and auditor
Beta Bionics, Inc. reported the results of its 2026 Annual Meeting of Stockholders.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
Beta Bionics, Inc. reported the results of its 2026 Annual Meeting of Stockholders. As of March 23, 2026, there were 44,561,695 shares outstanding, and a quorum of 36,061,048 shares was represented in person or by proxy.
Stockholders elected Class I directors Sean D. Carney and Christy Jones to serve until the 2029 Annual Meeting, with Carney receiving 30,659,060 votes for and Jones 25,865,542 votes for, alongside broker non-votes. Stockholders also ratified the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Shares outstanding: 44,561,695 shares
Quorum shares represented: 36,061,048 shares
Votes for Sean D. Carney: 30,659,060 votes
+5 more
8 metrics
Shares outstanding
44,561,695 shares
Common stock outstanding as of March 23, 2026 record date
Quorum shares represented
36,061,048 shares
Shares represented in person or by proxy at Annual Meeting
Votes for Sean D. Carney
30,659,060 votes
Election of Class I director
Votes for Christy Jones
25,865,542 votes
Election of Class I director
Broker non-votes (directors)
4,792,996 votes
Broker non-votes reported for each director election
Votes for auditor ratification
36,011,432 votes
Ratification of Ernst & Young LLP for FY ending Dec. 31, 2026
Votes against auditor ratification
41,527 votes
Ratification of Ernst & Young LLP
Abstentions on auditor ratification
8,089 votes
Ratification of Ernst & Young LLP
Key Terms
Annual Meeting of Stockholders, quorum, Class I directors, independent registered public accounting firm, +1 more
5 terms
Annual Meeting of Stockholders financial
"held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”)."
quorum financial
"At the Annual Meeting, a quorum of 36,061,048 shares of the Company’s common stock were represented"
A quorum is the minimum number of members needed to officially hold a meeting or make decisions. It ensures that decisions are made with enough participation to represent the group’s interests, much like a majority must be present for a vote to be valid. For investors, understanding quorum is important because it affects when and how important company or organization decisions can be legally made.
Class I directors financial
"elected two Class I directors, Sean D. Carney and Christy Jones, to hold office"
Class I directors are the subset of a company’s board whose terms expire at a specific annual meeting under a staggered election system that divides directors into multiple groups with different re-election years. For investors this matters because staggered classes slow how quickly shareholders can replace the board, affecting takeover risk, governance change and the pace of corporate decisions — like rotating only part of a team instead of swapping everyone at once.
independent registered public accounting firm financial
"ratified the appointment by the Audit Committee ... of Ernst & Young LLP as the Company’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
broker non-votes financial
"Votes For | Votes Withheld | Broker Non-Votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Beta Bionics (BBNX) report from its 2026 Annual Meeting?
Beta Bionics reported final voting results from its 2026 Annual Meeting. Stockholders elected two Class I directors and ratified Ernst & Young LLP as independent auditor for the fiscal year ending December 31, 2026, with a quorum of 36,061,048 shares represented.
Which directors were elected at the 2026 Beta Bionics (BBNX) Annual Meeting?
Stockholders elected Sean D. Carney and Christy Jones as Class I directors. They will serve until the 2029 Annual Meeting of Stockholders, or until earlier death, resignation, or removal, following majority support in the director election vote at the meeting.
What were the vote totals for Beta Bionics (BBNX) director elections?
Sean D. Carney received 30,659,060 votes for and 608,992 withheld, with 4,792,996 broker non-votes. Christy Jones received 25,865,542 votes for and 5,402,510 withheld, plus the same 4,792,996 broker non-votes reported in the director election results.
Which auditor did Beta Bionics (BBNX) stockholders ratify for 2026?
Stockholders ratified Ernst & Young LLP as Beta Bionics’ independent registered public accounting firm. For this proposal, 36,011,432 votes were cast for ratification, 41,527 against, and 8,089 abstentions for the fiscal year ending December 31, 2026.
Were there any other proposals at the 2026 Beta Bionics (BBNX) Annual Meeting?
No additional proposals were presented for stockholder approval. The meeting addressed only two items: election of the two Class I directors and ratification of Ernst & Young LLP as the independent registered public accounting firm for the 2026 fiscal year.
AI-generated analysis. How Rhea-AI works. Not financial advice.
